Prevention of pain on injection with propofol: Comparison of lignocaine with dilution using 0.9% Sodium Chloride

ISRCTN ISRCTN19276105
DOI https://doi.org/10.1186/ISRCTN19276105
Secondary identifying numbers N0234131723
Submission date
30/09/2004
Registration date
30/09/2004
Last edited
30/03/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Signs and Symptoms
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr A P Madden
Scientific

Department of Anaesthetics
North Bristol NHS Trust
Southmead Hospital
Westbury-on-Trym
Bristol
BS10 5NB
United Kingdom

Phone +44 (0)117 959 5114
Email abc@email.com

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific titlePrevention of pain on injection with propofol: Comparison of lignocaine with dilution using 0.9% Sodium Chloride
Study objectivesWill the dilution of Fresenius 1% propofol using equal parts of 0.9% Sodium Chloride and 1% Fresenius propofol reduce the incidence of pain on injection in children aged 5 to 10 years?
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedRespiratory: Pain
InterventionChildren aged 5-10 years (up to approximately 30 kg) will be randomised to either a sample or control group. A single blinded observer will then watch for signs of discomfort on induction of anaesthesia during the injection of propofol. This will be defined as a motor response of the arm, a verbal complaint of pain, a cry and or grimace.
Intervention typeOther
Primary outcome measureA reduction in the incidence of pain on injection of Propofol when compared with the most commonly used and effective method in current practice (i.e. the addition of lignocaine - 2 ml 1% per 20 ml propofol).
Secondary outcome measuresNot provided at time of registration
Overall study start date01/11/2003
Completion date01/07/2004

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit5 Years
Upper age limit10 Years
SexBoth
Target number of participantsNot provided at time of registration
Key inclusion criteriaChildren aged 5-10 years (up to approximately 30 kg) with American Society of Anesthesiologists (ASA) status 1 or 2 on elective surgical lists.
Key exclusion criteriaDoes not match inclusion criteria
Date of first enrolment01/11/2003
Date of final enrolment01/07/2004

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Department of Anaesthetics
Bristol
BS10 5NB
United Kingdom

Sponsor information

Department of Health
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Hospital/treatment centre

North Bristol NHS Trust (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

30/03/2020: No publications found. All search options exhausted.